Selective Estrogen Receptor Modulators


Uses

  • Critical components in treatment algorithm for invasive and/or in situ breast cancer, breast cancer chemoprevention in high-risk pts, and postmenopausal osteoporosis (raloxifene only)

Perioperative Risks

  • VTE, particularly if the pt has a history of recent chemotherapy, prior irradiation, or long-term SERM use

  • Microvascular complications following free-flap breast reconstruction surgery

Worry About

  • Periop SERM management

  • Endometrial cancer (tamoxifen only)

  • Unpleasant side effect profile affecting pt quality of life and medication adherence

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here